For the Inventor, By the Inventor

Enter assignee name

Bracco S.p.a.

USPTO Granted Patents = 12

% Expired Patents = 33.3

EPO Patents = 2

Trademarks = 5

Forward Citations = 180

Loading Chart...

Loading Chart...

36 inventors (with patents filed for the assignee):

Federico Maisano (2 out of 13 patents)

Livio Cavalieri (2 out of 4 patents)

Giovanni Rivolta (2 out of 3 patents)

4. Fulvia Vella (2 out of 4 patents)

5. Bruno Macchia (2 out of 3 patents)

6. Aldo Balsamo (2 out of 3 patents)

7. Marco Macchia (2 out of 3 patents)

8. Mario Del Tacca (2 out of 3 patents)

9. Romano Danesi (2 out of 4 patents)

10. Alessandro Maiocchi (1 out of 22 patents)

11. Silvio Aime (1 out of 31 patents)

12. Pier Lucio Anelli (1 out of 30 patents)

13. Michel Schneider (1 out of 79 patents)

14. Aldo Pinchera (1 out of 2 patents)

15. Ferruccio Santini (1 out of 2 patents)

12 patents: Sort by Forward Citations

1. 10238615 - 3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof (2019-03-26),

2. 9468619 - 3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof (2016-10-18),

3. 9044441 - 3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof (2015-06-02),

4. 7807395 - Method for the determination of prosthetic infections (2010-10-05),

5. 7214794 - Ceramide analogs, process for their preparation and their use as antitumor agents (2007-05-08),

6. 6956109 - Ceramide analogs, process for their preparation and their use as antitumor agents (2005-10-18),

7. 6509324 - Chelating compounds, their complexes with paramagnetic metals (2003-01-21),

8. 6321105 - Method for diagnosing neurological, neurodegenerative and psychiatric diseases by magnetic resonance imaging using contrast agents with high magnetic susceptibility and extended plasma half life (2001-11-20),

9. 5626832 - Injectable opacifying composition containing liposomes of high (1997-05-06),

10. 5599931 - Process for separating stereoisomers of folinic acid (1997-02-04),

11. 5380281 - Device for the administration of drugs, particularly two-component drugs (1995-01-10),

12. 5368839 - Insoluble salts of lanthanides for the visual display using nuclear (1994-11-29),

Company Overview

Bracco S.p.a., headquartered in Milan, Italy, is a prominent player in the healthcare sector, specializing in the development and manufacturing of diagnostic imaging solutions. The company focuses on contrast agents and advanced imaging technologies that enhance the accuracy of medical diagnoses. With a commitment to innovation, Bracco invests in research and development to improve patient outcomes and support healthcare professionals globally. Its expertise spans various imaging modalities, including MRI, CT, and ultrasound, positioning it as a leader in the medical imaging field.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#144 in Milan

#767 in Italy

#48,163 in the World

Bracco S.p.a.

Forward Citations = 180

36 inventors:

Federico Maisano (2 out of 13 patents)

Livio Cavalieri (2 out of 4 patents)

Giovanni Rivolta (2 out of 3 patents)

4. Fulvia Vella (2 out of 4 patents)

5. Bruno Macchia (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bracco S.p.a.. Retrieved from https://idiyas.com/company/bracco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…